Synopsis
Synopsis
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2-(2-hydroxyethoxy)-ethyl-n-(alpha,alpha,alpha-trifluoro- M-tolyl)anthranilate
2. Algesalona E
3. Aspitopic
4. Bayro
5. Flogoprofen
6. Rheuma-gel-ratiopharm
7. Rheumon
8. Traumon
9. Zenavan
1. 30544-47-9
2. Bay D 1107
3. 2-(2-hydroxyethoxy)ethyl 2-((3-(trifluoromethyl)phenyl)amino)benzoate
4. 2-(2-hydroxyethoxy)ethyl 2-[3-(trifluoromethyl)anilino]benzoate
5. Tvx485
6. 2-(2-hydroxyethoxy)ethyl 2-{[3-(trifluoromethyl)phenyl]amino}benzoate
7. Whr-5020
8. Bayrogel
9. Rheumon
10. Kzf0xm66jc
11. Bayd-1107
12. Tvx-485
13. Bay-d-1107
14. 2-(2-hydroxyethoxy)ethyl-n-(alpha,alpha,alpha-trifluoro-m-tolyl)anthranilate
15. Benzoic Acid, 2-((3-(trifluoromethyl)phenyl)amino)-, 2-(2-hydroxyethoxy)ethyl Ester
16. Ncgc00016804-01
17. Rheumon Gel
18. Cas-30544-47-9
19. Benzoic Acid, 2-[[3-(trifluoromethyl)phenyl]amino]-, 2-(2-hydroxyethoxy)ethyl Ester
20. Dsstox_cid_25448
21. Dsstox_rid_80887
22. Dsstox_gsid_45448
23. Etofenamato
24. Etofenamatum
25. Etofenamatum [inn-latin]
26. Etofenamato [inn-spanish]
27. Tvx 485
28. Whr 5020
29. Einecs 250-231-8
30. Unii-kzf0xm66jc
31. Brn 2953263
32. Etofenamate [usan:inn:ban]
33. 2-(2-hydroxyethoxy)ethyl Fufenamate
34. 2-(2-hydroxyaethoxy)aethylester Der Flutenaminsaeure [german]
35. Etofenamate [mi]
36. Prestwick0_001014
37. Prestwick1_001014
38. Prestwick2_001014
39. Etofenamate [inn]
40. Etofenamate [jan]
41. Etofenamate (usan/inn)
42. Etofenamate [usan]
43. 2-(2-hydroxyethoxy)ethyl N-(alpha,alpha,alpha-trifluoro-m-tolyl)anthranilate
44. Etofenamate [mart.]
45. Schembl25152
46. Etofenamate [who-dd]
47. 2-(2-hydroxyaethoxy)aethylester Der Flutenaminsaeure
48. Spbio_003038
49. Chembl1451633
50. Dtxsid2045448
51. Chebi:94731
52. Ex-a275
53. Etofenamate [ep Monograph]
54. Etofenamate For Peak Identification
55. Hms1571k09
56. Hms3713h06
57. Bcp08746
58. Zinc2034516
59. Tox21_110618
60. Mfcd00242806
61. S6742
62. Akos026750534
63. Tox21_110618_1
64. Ccg-220592
65. Cs-0905
66. Db08984
67. Anthranilic Acid, N-(alpha,alpha,alpha-trifluoro-m-tolyl)-, 2-(2-hydroxyethoxy)ethyl Ester
68. Ncgc00016804-02
69. Ncgc00016804-03
70. Ac-35208
71. As-73948
72. Da-33632
73. Hy-17361
74. Ft-0668428
75. D04102
76. 544e479
77. Q414378
78. Sr-01000872640
79. J-018005
80. Sr-01000872640-1
81. Brd-k73541271-001-01-0
82. Z1248763315
83. 2-[3-(trifluoromethyl)anilino]benzoic Acid 2-(2-hydroxyethoxy)ethyl Ester
84. Tv-485;tv485;tv 485; Whr-5020; Whr 5020; Whr5020
85. 2-(2-hydroxyethoxy)ethyl N-(.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)anthranilate
Molecular Weight | 369.3 g/mol |
---|---|
Molecular Formula | C18H18F3NO4 |
XLogP3 | 4.7 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 9 |
Exact Mass | 369.11879254 g/mol |
Monoisotopic Mass | 369.11879254 g/mol |
Topological Polar Surface Area | 67.8 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 433 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
M02AA06
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
M - Musculo-skeletal system
M02 - Topical products for joint and muscular pain
M02A - Topical products for joint and muscular pain
M02AA - Antiinflammatory preparations, non-steroids for topical use
M02AA06 - Etofenamate
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Switzerland
Brand Name : Lixim Patch
Dosage Form : Pfl
Dosage Strength : 70mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Rheumalix
Dosage Form : Gel
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Rheumalix
Dosage Form : Gel
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Rheumalix forte
Dosage Form : Spray
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Rheumalix forte
Dosage Form : Gel
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Traumalix forte
Dosage Form : Spray
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Traumalix forte
Dosage Form : Gel
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Traumalix forte
Dosage Form : Gel
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Traumalix forte EmGel
Dosage Form : Emulgel
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info : EU CTD Dossier- Ready
Registration Country : Portugal
Brand Name :
Dosage Form : Gel
Dosage Strength : 100MG/1G
Packaging : 1 Tube 100 G
Approval Date :
Application Number :
Regulatory Info : EU CTD Dossier- Ready
Registration Country : Portugal
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Etofenamate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Etofenamate, including repackagers and relabelers. The FDA regulates Etofenamate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Etofenamate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Etofenamate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Etofenamate supplier is an individual or a company that provides Etofenamate active pharmaceutical ingredient (API) or Etofenamate finished formulations upon request. The Etofenamate suppliers may include Etofenamate API manufacturers, exporters, distributors and traders.
click here to find a list of Etofenamate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Etofenamate DMF (Drug Master File) is a document detailing the whole manufacturing process of Etofenamate active pharmaceutical ingredient (API) in detail. Different forms of Etofenamate DMFs exist exist since differing nations have different regulations, such as Etofenamate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Etofenamate DMF submitted to regulatory agencies in the US is known as a USDMF. Etofenamate USDMF includes data on Etofenamate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Etofenamate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Etofenamate suppliers with USDMF on PharmaCompass.
A Etofenamate CEP of the European Pharmacopoeia monograph is often referred to as a Etofenamate Certificate of Suitability (COS). The purpose of a Etofenamate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Etofenamate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Etofenamate to their clients by showing that a Etofenamate CEP has been issued for it. The manufacturer submits a Etofenamate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Etofenamate CEP holder for the record. Additionally, the data presented in the Etofenamate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Etofenamate DMF.
A Etofenamate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Etofenamate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Etofenamate suppliers with CEP (COS) on PharmaCompass.
A Etofenamate written confirmation (Etofenamate WC) is an official document issued by a regulatory agency to a Etofenamate manufacturer, verifying that the manufacturing facility of a Etofenamate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Etofenamate APIs or Etofenamate finished pharmaceutical products to another nation, regulatory agencies frequently require a Etofenamate WC (written confirmation) as part of the regulatory process.
click here to find a list of Etofenamate suppliers with Written Confirmation (WC) on PharmaCompass.
Etofenamate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Etofenamate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Etofenamate GMP manufacturer or Etofenamate GMP API supplier for your needs.
A Etofenamate CoA (Certificate of Analysis) is a formal document that attests to Etofenamate's compliance with Etofenamate specifications and serves as a tool for batch-level quality control.
Etofenamate CoA mostly includes findings from lab analyses of a specific batch. For each Etofenamate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Etofenamate may be tested according to a variety of international standards, such as European Pharmacopoeia (Etofenamate EP), Etofenamate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Etofenamate USP).
LOOKING FOR A SUPPLIER?